Comparison of high dose rapid schedule with conventional schedule chemotherapy for stage IV neuroblastoma over the age of one year
Completed
- Conditions
- Brain and nervous system cancerCancerBrain and nervous system
- Registration Number
- ISRCTN67769193
- Lead Sponsor
- Cancer Research UK (CRUK) (UK)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Biopsy proven stage IV neuroblastoma
2. Over 1 year of age at diagnosis
3. No previous chemotherapy
Exclusion Criteria
Not provided at time of registration
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method